Skip to main content
Top

Current Oncology Reports

Issue 5/2023

Content (12 Articles)

Artificial Intelligence and Cancer Control: Toward Prioritizing Justice, Equity, Diversity, and Inclusion (JEDI) in Emerging Decision Support Technologies

Peter Taber, Julie S. Armin, Gabriela Orozco, Guilherme Del Fiol, Jennifer Erdrich, Kensaku Kawamoto, Sonoo Thadaney Israni

Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment

Nikhil Yegya-Raman, Eva Berlin, Steven J. Feigenberg, Bonnie Ky, Lova Sun

Clonal Hematopoiesis and the Heart: a Toxic Relationship

Jeffrey L. Jensen, Saumya Easaw, Travis Anderson, Yash Varma, Jiandong Zhang, Brian C. Jensen, Catherine C. Coombs

Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)

Grace Kong, Emma Boehm, Owen Prall, William K. Murray, Richard W. Tothill, Michael Michael

Open Access Solid Tumor

CAR-T Therapies in Solid Tumors: Opportunities and Challenges

Grace Guzman, Megan R. Reed, Kevin Bielamowicz, Brian Koss, Analiz Rodriguez

Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review

Sam Dowthwaite, James Jackson, Marcin Dzienis, Eric Khoo, Mathew Cronin, Emily Guazzo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine